{{Rsnum
|rsid=1566039
|Chromosome=5
|position=6821801
|Orientation=plus
|GMAF=0.4513
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 11.5 | 38.9 | 49.6
| HCB | 53.3 | 38.0 | 8.8
| JPT | 32.7 | 51.3 | 15.9
| YRI | 8.2 | 52.4 | 39.5
| ASW | 22.8 | 38.6 | 38.6
| CHB | 53.3 | 38.0 | 8.8
| CHD | 57.8 | 36.7 | 5.5
| GIH | 9.9 | 50.5 | 39.6
| LWK | 18.2 | 48.2 | 33.6
| MEX | 19.0 | 51.7 | 29.3
| MKK | 14.1 | 41.0 | 44.9
| TSI | 15.7 | 48.0 | 36.3
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22359512
|Trait=None
|Title=Genome-wide association study identifies novel loci associated with circulating phospho- and sphingolipid concentrations.
|RiskAllele=
|Pval=1E-8
|OR=0.8000
|ORtxt=None
|OA=1
}}

{{PMID Auto
|PMID=23543094
|Title=Testing for associations between loci and environmental gradients using latent factor mixed models.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}